North America Artificial Intelligence In Drug Discovery Market Size & Outlook
- Healthcare IT
- AI in Healthcare
- Artificial Intelligence in Drug Discovery Market Outlook
- AI in Healthcare
Global Market
Related Markets
Ask Prism AI about the artificial intelligence in drug discovery market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
North America artificial intelligence in drug discovery market highlights
- The North America artificial intelligence in drug discovery market generated a revenue of USD 1,239.7 million in 2025.
- The market is expected to grow at a CAGR of 23.7% from 2026 to 2033.
- In terms of segment, neurodegenerative diseases was the largest revenue generating therapeutic space in 2025.
- Infectious Disease is the most lucrative therapeutic space segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2026 to 2033.
North America data book summary
| Market revenue in 2025 | USD 1,239.7 million |
| Market revenue in 2033 | USD 6,774.8 million |
| Growth rate | 23.7% (CAGR from 2026 to 2033) |
| Largest segment | Neurodegenerative diseases |
| Fastest growing segment | Infectious Disease |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oncology, Neurodegenerative Diseases, Cardiovascular Disease, Metabolic Diseases, Infectious Disease, Other |
| Key market players worldwide | International Business Machines Corp, Exscientia PLC ADR, Insilico Medicine, Aitia, Alphabet Inc Class A, Benevolent AI, BioSymetrics, Atomwise, Insitro, Recursion Pharmaceuticals Inc Class A |
Other key industry trends
- In terms of revenue, North America region accounted for 52.9% of the global artificial intelligence in drug discovery market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 3,008.7 million by 2033.
Strong economic growth and presence of well-equipped hospitals, research centers, universities, & medical device manufacturers are factors boosting the development of new products in this region.
In addition, increasing need for managing & controlling overall costs & time associated with discovery & development of drugs, increasing cross-industry collaborations & partnerships, surge in the adoption of cloud-based services & applications, and impending patent expiry of blockbuster drugs are expected to further drive the market in North America.
For instance, in May 2018, Intel announced its collaboration with Novartis for using deep neural networks to increase high-content screening to support early drug discovery. The current COVID-19 pandemic has further created a sense of urgency, which in turn, is improving the demand for AI in drug discovery.
No credit card required*
Publish Date: Apr 21, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Artificial Intelligence In Drug Discovery Market Scope
Artificial Intelligence In Drug Discovery Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| International Business Machines Corp | View profile | 282,200 | One New Orchard Road, Armonk, NY, United States, 10504 | www.ibm.com |
| Alphabet Inc Class A | View profile | 180,895 | 1600 Amphitheatre Parkway, Mountain View, CA, United States, 94043 | www.abc.xyz |
| Exscientia PLC ADR | View profile | 483 | Oxford Science Park, The Schrodinger Building, Oxford, United Kingdom, OX4 4GE | www.exscientia.ai |
| Insilico Medicine | View profile | 101-250 | Hong Kong, Hong Kong Island, Hong Kong, Asia | www.insilico.com |
| Aitia | View profile | 51-100 | Somerville, Massachusetts, United States, North America | www.aitiabio.com/ |
| Benevolent AI | View profile | 248 | 4-8 Maple Street, London, United Kingdom, W1T 5HD | www.benevolent.com |
| Recursion Pharmaceuticals Inc Class A | View profile | 500 | 41 S Rio Grande Street, Salt Lake City,, UT, United States, 84101 | www.recursion.com |
| BioSymetrics | View profile | 11-50 | New York, New York, United States, North America | www.biosymetrics.com |
| Atomwise | View profile | 51-100 | San Francisco, California, United States, North America | www.atomwise.com |
| Insitro | View profile | 101-250 | South San Francisco, California, United States, North America | www.insitro.com |
North America Artificial Intelligence in Drug Discovery Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Artificial Intelligence in Drug Discovery Market Outlook will help companies and investors design strategic landscapes.
Neurodegenerative Diseases was the largest segment with a revenue share of 26.59% in 2025.
Horizon Databook has segmented the North America artificial intelligence in drug discovery market based on oncology, neurodegenerative diseases, cardiovascular disease, metabolic diseases, infectious disease, other covering the revenue growth of each sub-segment from 2021 to 2033.
Strong economic growth and presence of well-equipped hospitals, research centers, universities, & medical device manufacturers are factors boosting the development of new products in this region.
In addition, increasing need for managing & controlling overall costs & time associated with discovery & development of drugs, increasing cross-industry collaborations & partnerships, surge in the adoption of cloud-based services & applications, and impending patent expiry of blockbuster drugs are expected to further drive the market in North America.
For instance, in May 2018, Intel announced its collaboration with Novartis for using deep neural networks to increase high-content screening to support early drug discovery. The current COVID-19 pandemic has further created a sense of urgency, which in turn, is improving the demand for AI in drug discovery.
- North America Artificial Intelligence In Drug Discovery Market Therapeutic Space Outlook (Revenue, USD Million , 2021-2033)
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Other
- North America Artificial Intelligence In Drug Discovery Market Application Outlook (Revenue, USD Million , 2021-2033)
- Drug optimisation and repurposing
- Preclinical testing
- Others
Reasons to subscribe to Artificial Intelligence in Drug Discovery Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Artificial Intelligence in Drug Discovery Market Outlook databook
- Our clientele includes a mix of Artificial Intelligence in Drug Discovery Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America Artificial Intelligence in Drug Discovery Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into North America Artificial Intelligence in Drug Discovery Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
North America Artificial Intelligence In Drug Discovery Market, 2021-2033 (US$M)
North America artificial intelligence in drug discovery market statistics, by therapeutic space, 2021-2033 (US$M)
